Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Ophthalmology
•
Vitreoretinal Diseases and Surgery
How should diabetic retinopathy surveillance be adjusted for patients starting GLP-1 agonists?
Related Questions
When should delayed removal of an intraocular foreign body be considered?
What factors guide the decision to treat with ROP laser treatment versus a repeat anti-VEGF injection in a child who has previously received anti-VEGF therapy for retinopathy of prematurity (ROP)?
How do you manage a situation where the lens optic shifts in front of the iris after a Yamane technique?
What factors influence the decision to initiate anti-VEGF injections to prevent radiation retinopathy after plaque brachytherapy?
What is your approach to antiviral treatment of HSV acute retinal necrosis?
How do you manage cystoid macular edema (CME) in patients with steroid-induced intraocular hypertension that is resistant to topical treatments?
Do you utilize thrombolytic therapy in patients with CRAO?
How do you manage macular-threatening toxoplasma chorioretinitis in pregnancy?
Do you routinely recommend IV systemic antibiotic therapy in additional to intravitreal antibiotic therapy for exogenous bacterial endophthalmitis?
How do you decide on when to start or continue anti-VEGF injections during pregnancy?
